123 related articles for article (PubMed ID: 12001767)
21. Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
McPake CR; Tillman DM; Poquette CA; George EO; Houghton JA; Harris LC
Oncol Res; 1998; 10(5):235-44. PubMed ID: 9802058
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis-associated proteins in oral lymphomas from HIV-positive patients.
Regezi JA; McMillan A; Dekker N; Daniels TE; Silverman S; Schoelch M; Ziober BL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):196-202. PubMed ID: 9720096
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
[TBL] [Abstract][Full Text] [Related]
24. The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment.
Skírnisdóttir I; Seidal T
Oncol Rep; 2012 Mar; 27(3):741-7. PubMed ID: 22159712
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of apoptotic markers in gastric cancer.
Smith L; Berrieman HK; O'Kane SL; Campbell A; Maraveyas A; Cawkwell L
Oncol Res; 2006; 15(9):441-4. PubMed ID: 16555550
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
Fracchiolla NS; Capaccio P; Carboni N; Pagliari AV; Neri A; Ronchett D; Pruner G; Silvotti MG; Pignataro L; Buffa R; Broich G
Anticancer Res; 1999; 19(2A):1043-51. PubMed ID: 10368653
[TBL] [Abstract][Full Text] [Related]
30. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.
Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E
Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
32. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
Itakura M; Mori S; Park NH; Bonavida B
Int J Oncol; 2000 Mar; 16(3):591-7. PubMed ID: 10675494
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
35. Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.
Ozer E; Canda MS; Ulukus C; Guray M; Erbayraktar S
Tumori; 2003; 89(1):54-9. PubMed ID: 12729363
[TBL] [Abstract][Full Text] [Related]
36. Expression of bax and p53 proteins in the tumorigenesis and progression of breast carcinomas.
Redondo M; Garcia J; Rodrigo I; Villar E; González C; Morell M
Tumour Biol; 2003; 24(1):23-31. PubMed ID: 12743423
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between p53, bax and bcl-2 expression and cell apoptosis in intrahepatic cholestasis of pregnancy].
Wang DM; Zhu QY; Ding L; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Jan; 38(1):5-7. PubMed ID: 12757648
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis dysregulation in human gastric carcinomas: relationship to anti- and pro-apoptotic protein expression.
Nasif WA; El-Emshaty HM; Lotfy M; Zalata K; El-Hak NG
Asian Pac J Cancer Prev; 2007; 8(1):45-50. PubMed ID: 17477770
[TBL] [Abstract][Full Text] [Related]
39. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.
Xiang J; Gómez-Navarro J; Arafat W; Liu B; Barker SD; Alvarez RD; Siegal GP; Curiel DT
J Gene Med; 2000; 2(2):97-106. PubMed ID: 10809143
[TBL] [Abstract][Full Text] [Related]
40. The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer.
Avraam K; Pavlakis K; Papadimitriou C; Vrekoussis T; Panoskaltsis T; Messini I; Patsouris E
Eur J Gynaecol Oncol; 2011; 32(5):516-20. PubMed ID: 22053665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
